Pricing Log in Create free account

Alumis Inc. (ALMS) vs Latigo Biotherapeutics Inc (LTGO)

Alumis Inc. and Latigo Biotherapeutics Inc are both Biotechnology companies. Alumis Inc. and Latigo Biotherapeutics Inc are of similar size ($883.8M and $854.4M). Latigo Biotherapeutics Inc has the higher net margin (0.00% vs −5,933.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 8 metrics below, Latigo Biotherapeutics Inc leads on 7 and Alumis Inc. on 1.

Valuation

Metric ALMS LTGO Biotechnology median
P/E n/m n/m 10.96
P/S 110.64 n/m 9.52
P/B 1.81 1.28 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 42.74 n/m 9.00
Earnings yield (59.17%) (620.21%) (32.09%)
Free cash flow yield (42.98%) 0.00% (22.62%)

Profitability

Metric ALMS LTGO Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (6,204.39%) 0.00% 0.00%
Net margin (5,933.45%) 0.00% 0.00%
Free cash flow margin (4,755.33%) — 0.00%
Return on equity (93.65%) 0.00% (50.12%)
Return on assets (74.94%) 0.00% (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALMS LTGO Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) 72.45% — 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric ALMS LTGO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.74 29.11 4.74
Net debt to EBITDA 0.69 — 1.01

Dividend

Metric ALMS LTGO Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric ALMS LTGO Biotechnology median
Market cap 854.37m 883.77m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack